Vanderbilt Institute of Chemical Biology

January 5, 2022

VICB seminar features Lynmarie Thompson of the University of Massachusetts on Jan. 12

By VUMC News and Communications
January 27, 2020

A new contributor to atherosclerosis

Sean Davies and colleagues are exploring lipid aldehydes produced during oxidative stress and their contribution to HDL dysfunction and atherosclerosis.

By Leigh MacMillan
March 22, 2018

Founders’ Celebration for Institute of Chemical Biology set for March 28

The Vanderbilt Institute of Chemical Biology (VICB) will hold a Founders’ Celebration mini-symposium on March 28 to acknowledge the contributions of its founders, Lawrence Marnett, PhD, and Ned Porter, PhD, and to celebrate 15-plus years of success as a trans-institutional scientific incubator.

By Bill Snyder
January 16, 2018

A spicy finding

Vanderbilt researchers have discovered that curcumin — the active ingredient in the spice turmeric — needs to be metabolically activated to exert anti-inflammatory effects.

By Leigh MacMillan
H. Alex Brown, Ph.D.
July 26, 2017

Vanderbilt mourns loss of pharmacologist H. Alex Brown

H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology at Vanderbilt University School of Medicine, died from cancer Tuesday, July 25, at his home. He was 56.

By Bill Snyder
May 18, 2017

Oxidative stress in tumors

Vanderbilt investigators have developed a new method for measuring oxidative stress in human tumors, which provides insight into cancer development.

By Sanjay Mishra
November 3, 2016

Brown named interim director of Institute of Chemical Biology

H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology, has been named interim director of the Vanderbilt Institute of Chemical Biology (VICB).
By Bill Snyder
August 11, 2016

Transcription factor evolution

Vanderbilt researchers have discovered a novel model of evolution for factors that control gene expression.
By Sanjay Mishra
April 20, 2016

How strep grabs on to platelets

New structural details of the binding of the bacterium Streptococcus sanguinis to platelets may offer new therapeutics for life-threatening cardiovascular infections.
By VUMC News and Communications
April 7, 2016

Purdue’s Low set for next Flexner Discovery Lecture

Philip Low, Ph.D., director of the Purdue Center for Drug Discovery, will deliver the next Flexner Discovery Lecture on April 14.
By Bill Snyder
January 28, 2016

Nobel laureate’s lecture highlights impact of science

“Stay with science,” Nobel laureate Peter Agre, M.D., advised dozens of medical and graduate students who attended his lecture at Vanderbilt University Medical Center last week. “It will take you to fascinating places.”
By VUMC News and Communications
January 14, 2016

‘Science diplomacy’ focus of Nobel laureate Agre’s Discovery Lecture

Peter Agre, M.D., a Nobel laureate who advocates the use of medical science to advance international diplomacy, will deliver the next Flexner Discovery Lecture at 4 p.m. Thursday, Jan. 21, in room 208 Light Hall.
By Bill Snyder
October 2, 2015

The yin and yang of COX-2

New findings add to the understanding of how the enzyme COX-2 works, which is critical to the development of COX-2-targeted anti-inflammatory drugs.
By Sanjay Mishra
1 2 3